SUMMARY We have restudied a fibroblast cell line from a female with marked manifestations of X linked hypohidrotic ectodermal dysplasia (HED) and a balanced X;9 translocation. Chromosome analysis showed a karyotype of 46,X,t(X;9)(ql3 1;p24) with an Xq breakpoint distal to the one previously reported. The significance of the cell line, previously unrecognised, for the mapping and eventual cloning of the HED locus is discussed. 
The identification of females with X;autosome balanced translocations and marked manifestations of X linked disorders has assumed increasing importance over the past few years. It has become evident, as in the case of Duchenne muscular dystrophy (DMD), that such rare patients may not only supply a vital clue to the detailed localisation of the disorder, but in addition may assist in the actual cloning of the gene locus itself.1 2 It has recently been shown in DMD that the females with manifestations of the disorder have the breakpoints of their translocations within the disease locus.3 This is consistent with the theory that such translocations disrupt one normal allele in the formation of the derivative chromosomes and, with the usual preferential inactivation of the normal X chromosome in balanced X;autosome translocations, produces a phenotype similar to that of an affected hemizygous m1ale.
Several groups have been involved in the regional mapping of the X linked disorder hypohidrotic ectodermal dysplasia. Examination of the G banded preparations confirmed the presence of an X;9 balanced translocation. The breakpoints were at the junction of bands Xql2 and Xql3-1, or in the proximal region of Xql3-1 and at band 9p24, respectively (figs 1 and 2). There appears to be no reduction in the width of band Xql2 on the derivative X chromosome, nor is any dark band apparent at the junction of X and 9 chromosomal material on the derivative 9. The karyotype, according to conventional nomenclature,'3 was thus designated: 46,X,t(X;9)(Xpter-* Xq13-1: :9p24-*9pter;9qter-->9p24: :Xq 13. 1--Xqter). RBG banding showed the normal X chromosome to be late replicating in each of the 28 divisions examined. There was no evidence of late replication of either of the translocation products.
Discussion
The Shows and Brown'5 16 originally placed the breakpoint of the translocation at the junction of the Xqll and Xql2 bands, describing the karyotype as 46,X,t(Xq-;9p+)(ql2;p24). Our reanalysis of the cell line, with higher resolution chromosome studies, defines a slightly more distal breakpoint, at the junction of the Xql2 and Xql3*1 bands, or in the proximal region of Xq13-1. We confirmed the earlier finding (as expected) of inactivation of the normal X chromosome in all cells examined, but did not observe evidence of additional late replication of the Xq portion of the derivative chromosome 9, as initially reported by Cohen et a?9 in 32% of cells.
A number of investigators have continued to use the AnLy cell line, without apparent recognition of the patient's true phenotype, in the construction of somatic cell hybrids to localise both expressed genes and anonymous DNA marker loci.' 20 The wide use of somatic cell hybrids, derived from the AnLy line, by several groups physically mapping the pericentromeric region of the X chromosome, pro- The recognition of the full significance of the AnLy cell line should provide further opportunities for molecular studies. The location of the marker loci in relation to the translocation breakpoint, previously established by somatic cell studies, can be confirmed by in situ hybridisation studies on the fibroblast line, eliminating the problem of possible de novo chromosomal rearrangements in the somatic cell hybrids. Finally, although no simple task, the possibility now exists of isolating the junctional fragments from the derivative chromosomes, identifying RNA transcripts from these clones, and ultimately discovering the gene product necessary for normal ectodermal morphogenesis.
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